BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 19897040)

  • 1. Targeting the ubiquitin-proteasome system to activate wild-type p53 for cancer therapy.
    Allende-Vega N; Saville MK
    Semin Cancer Biol; 2010 Feb; 20(1):29-39. PubMed ID: 19897040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of different E3 ubiquitin ligases in regulation of the P53 tumor suppressor protein].
    Daks AA; Melino D; Barlev NA
    Tsitologiia; 2013; 55(10):673-87. PubMed ID: 25509121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WW domain-containing E3 ubiquitin protein ligase 1 targets p63 transcription factor for ubiquitin-mediated proteasomal degradation and regulates apoptosis.
    Li Y; Zhou Z; Chen C
    Cell Death Differ; 2008 Dec; 15(12):1941-51. PubMed ID: 18806757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cullin 5-RING E3 ubiquitin ligases, new therapeutic targets?
    Lamsoul I; Uttenweiler-Joseph S; Moog-Lutz C; Lutz PG
    Biochimie; 2016 Mar; 122():339-47. PubMed ID: 26253693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the ubiquitin proteasome system in hematologic malignancies.
    Sahasrabuddhe AA; Elenitoba-Johnson KS
    Immunol Rev; 2015 Jan; 263(1):224-39. PubMed ID: 25510280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting NEDD8-activated cullin-RING ligases for the treatment of cancer.
    Soucy TA; Smith PG; Rolfe M
    Clin Cancer Res; 2009 Jun; 15(12):3912-6. PubMed ID: 19509147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gambogic acid-induced degradation of mutant p53 is mediated by proteasome and related to CHIP.
    Wang J; Zhao Q; Qi Q; Gu HY; Rong JJ; Mu R; Zou MJ; Tao L; You QD; Guo QL
    J Cell Biochem; 2011 Feb; 112(2):509-19. PubMed ID: 21268072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 Ubiquitination and proteasomal degradation.
    Love IM; Shi D; Grossman SR
    Methods Mol Biol; 2013; 962():63-73. PubMed ID: 23150437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the ubiquitin-mediated proteasome degradation of p53 for cancer therapy.
    Devine T; Dai MS
    Curr Pharm Des; 2013; 19(18):3248-62. PubMed ID: 23151129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the ubiquitin pathway for cancer treatment.
    Liu J; Shaik S; Dai X; Wu Q; Zhou X; Wang Z; Wei W
    Biochim Biophys Acta; 2015 Jan; 1855(1):50-60. PubMed ID: 25481052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulation of ubiquitin ligases in cancer.
    Qi J; Ronai ZA
    Drug Resist Updat; 2015 Nov; 23():1-11. PubMed ID: 26690337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete reconstitution of conjugation and subsequent degradation of the tumor suppressor protein p53 by purified components of the ubiquitin proteolytic system.
    Shkedy D; Gonen H; Bercovich B; Ciechanover A
    FEBS Lett; 1994 Jul; 348(2):126-30. PubMed ID: 8034027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The tumor suppressor HACE1 targets Rac1 to ubiquitin-mediated proteasomal degradation].
    Gacon G; Mettouchi A; Lemichez E
    Med Sci (Paris); 2012 Jan; 28(1):39-41. PubMed ID: 22289828
    [No Abstract]   [Full Text] [Related]  

  • 14. The Regulation of Tumor Suppressor p63 by the Ubiquitin-Proteasome System.
    Armstrong SR; Wu H; Wang B; Abuetabh Y; Sergi C; Leng RP
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27929429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ubiquitin-proteasome system and cancer.
    Devoy A; Soane T; Welchman R; Mayer RJ
    Essays Biochem; 2005; 41():187-203. PubMed ID: 16250906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ubiquitin-mediated protein degradation pathway in cancer: therapeutic implications.
    Burger AM; Seth AK
    Eur J Cancer; 2004 Oct; 40(15):2217-29. PubMed ID: 15454246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the ubiquitin-proteasome system for cancer therapy.
    Yang Y; Kitagaki J; Wang H; Hou DX; Perantoni AO
    Cancer Sci; 2009 Jan; 100(1):24-8. PubMed ID: 19037995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitination: Friend and foe in cancer.
    Mansour MA
    Int J Biochem Cell Biol; 2018 Aug; 101():80-93. PubMed ID: 29864543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hidden targets of ubiquitin proteasome system: To prevent diabetic nephropathy.
    Goru SK; Kadakol A; Gaikwad AB
    Pharmacol Res; 2017 Jun; 120():170-179. PubMed ID: 28363724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of ubiquitin signaling in transcription regulation.
    Hammond-Martel I; Yu H; Affar EB
    Cell Signal; 2012 Feb; 24(2):410-421. PubMed ID: 22033037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.